Peptide Lab HQ Research Guide
DSIP
A research-focused compound profile covering DSIP identity, delta sleep-inducing peptide research, sleep-architecture models, stress-response context, concentration reference, reconstitution reference, and safety considerations.
Compound Data
Compound Profile
| Compound Name | DSIP |
|---|---|
| Full Name | Delta Sleep-Inducing Peptide |
| Synonym | Emideltide |
| Compound Type | Synthetic neuropeptide / sleep-architecture research peptide |
| CAS Number | 62568-57-4 |
| Amino Acid Length | 9 amino acids |
| Amino Acid Sequence | Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu |
| Short Sequence | WAGGDASGE |
| Molecular Formula | C₃₅H₄₈N₁₀O₁₅ |
| Molecular Weight | Approximately 848.8–849 g/mol |
| Research Category | Sleep architecture, delta-wave sleep, stress-response, neuroendocrine, and CNS peptide research |
| Appearance | White to off-white lyophilized powder |
| Use | For laboratory research use only. |
Research Applications
Key Research Applications
DSIP is commonly discussed in controlled research models involving sleep architecture, delta-wave sleep patterns, stress-response signaling, neuroendocrine modulation, and CNS peptide research.
Sleep Architecture Research
DSIP is frequently discussed in research involving sleep quality, sleep continuity, sleep latency, and overall sleep-stage organization.
Delta-Wave Sleep Models
Originally named for its association with delta sleep, DSIP is studied in models involving slow-wave sleep, EEG activity, and sleep-depth observations.
Stress-Response Research
DSIP has been explored in research involving stress-response markers, HPA-axis signaling, cortisol-related observations, and neuroendocrine regulation.
Neuroendocrine Studies
Relevant to research involving hypothalamic, pituitary, and peripheral peptide signaling pathways.
Insomnia Study Context
Small human studies have evaluated DSIP in insomnia-related models, though findings have been limited, mixed, and not sufficient to establish standardized clinical use.
CNS Peptide Research
DSIP remains a research peptide of interest in CNS signaling, sleep regulation, peptide distribution, and brain-body communication models.
Research Scope
These applications are provided for educational and research-reference purposes only. DSIP research remains limited and mixed, and outcomes may vary based on study model, route, timing, purity, concentration, and laboratory conditions.
Reference Only
Reconstitution / Research Dosing Reference
Select Reference Vial
Select a vial size to update the concentration, U-100 unit references, and frequency table below.
Quick Reference Summary
| Reference Vial | 2 mg DSIP |
|---|---|
| Primary Solution Volume | 2.0 mL bacteriostatic water |
| Primary Concentration | 1 mg/mL |
| Measurement Reference | On a U-100 syringe, 1 unit = 0.01 mL. |
| Amount per U-100 Unit | At 1 mg/mL, 1 unit equals 0.01 mg / 10 mcg DSIP. |
| Storage Reference | Refrigerate at 2–8°C / 35.6–46.4°F after reconstitution, protected from direct light. |
Reconstitution Steps
- Draw 2.0 mL bacteriostatic water using a sterile syringe for the main concentration reference shown below.
- Slowly add the BAC water down the side of the vial wall.
- Gently roll or swirl the vial until the material is completely dissolved. The solution should appear clear to slightly hazy depending on concentration and supplier format. Do not shake!
- For higher-concentration preparations, verify that the material is fully dissolved before recording the final preparation details.
- Label with compound name, vial amount, concentration, solvent volume, preparation date, storage conditions, and handling notes.
- Store refrigerated at 2–8°C / 35.6–46.4°F, protected from direct light.
Published Research Context
| Reference Type | Reported Amount / Context | Research Notes |
|---|---|---|
| Compound Identity Reference | DSIP, delta sleep-inducing peptide | DSIP is commonly discussed as a neuromodulatory nonapeptide in sleep, neuroendocrine, stress-response, and CNS marker research contexts. |
| Sequence Reference | Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu / WAGGDASGE | This sequence is commonly listed for delta sleep-inducing peptide in peptide reference contexts. |
| Sleep / EEG Research Context | Delta-wave, sleep-latency, and sleep-efficiency research context | DSIP has been discussed in sleep-quality, sleep-latency, sleep-efficiency, EEG delta-wave, and sleep-stage observation research contexts. |
| Stress-Response Research Context | Model-dependent stress and metabolic-disturbance context | DSIP-related research has discussed attenuation of stress-induced metabolic disturbances, stress-response markers, respiration markers, and adaptive-response endpoints. |
| Neuroendocrine Research Context | Hypothalamic / pituitary signaling context | Research discussions commonly include hypothalamic, pituitary, peptide-signaling, endocrine-marker, and neuropeptide regulatory observations depending on the model. |
| Monoamine / CNS Marker Research | MAO-A, serotonin, and neurotransmitter-marker context | DSIP has appeared in research involving stress-induced monoamine oxidase activity changes, serotonin-level markers, and CNS stress-response observations. |
| Public Protocol-Style Reference | Microgram-to-milligram reference examples | Public protocol-style references commonly describe DSIP in microgram-to-milligram examples depending on the research model and preparation format. These are not clinical dosing standards. |
| Clinical / Research-Chemical Status | No universal research-chemical protocol established | Published study references, clinical-study contexts, public protocol-style references, or wellness protocols should not be treated as dosing instructions for research-chemical vial formats. |
Concentration Reference
| Vial Amount | Solution Volume | Final Concentration |
|---|---|---|
| 2 mg | 2.0 mL | 1 mg/mL |
| 5 mg | 2.0 mL | 2.5 mg/mL |
| 10 mg | 2.0 mL | 5 mg/mL |
| 20 mg | 3.0 mL | 6.67 mg/mL |
Research Dosing Amount / Volume Reference
| Reference Amount | Volume at 1 mg/mL | U-100 Unit Reference | Approx. References per 2 mg Vial |
|---|---|---|---|
| 25 mcg | 0.025 mL | 2.5 units | 80 |
| 50 mcg | 0.05 mL | 5 units | 40 |
| 0.1 mg / 100 mcg | 0.10 mL | 10 units | 20 |
| 0.25 mg / 250 mcg | 0.25 mL | 25 units | 8 |
| 0.5 mg / 500 mcg | 0.50 mL | 50 units | 4 |
| 1 mg / 1000 mcg | 1.00 mL | 100 units | 2 |
| 2 mg / 2000 mcg | 2.00 mL | 200 units | 1 |
| 5 mg / 5000 mcg | 5.00 mL | 500 units | 0.4 |
| 10 mg / 10000 mcg | 10.00 mL | 1000 units | 0.2 |
| 20 mg / 20000 mcg | 20.00 mL | 2000 units | 0.1 |
Research Frequency / Amount Reference
| Research Window | Frequency | Reference Amount | Units / Volume Reference |
|---|---|---|---|
| Lower Microgram Reference | Calculation reference only | 25 mcg reference amount | 2.5 units / 0.025 mL |
| Standard Microgram Reference | Calculation reference only | 50 mcg reference amount | 5 units / 0.05 mL |
| Low Milligram Conversion Example | Public protocol-style reference, not a clinical dosing standard | 0.1 mg reference amount | 10 units / 0.10 mL |
| Mid-Range Conversion Example | Public protocol-style reference, not a clinical dosing standard | 250 mcg reference amount | 25 units / 0.25 mL |
| Upper Conversion Example | Calculation reference only | 0.5 mg reference amount | 50 units / 0.50 mL |
| High Conversion Example | Calculation reference only | 1 mg reference amount | 100 units / 1.00 mL |
| 2 mg Preparation Reference | Preparation-level calculation reference | 2 mg reference amount | 200 units / 2.00 mL |
| 5 mg Preparation Reference | Preparation-level calculation reference | 5 mg reference amount | 500 units / 5.00 mL |
| 10 mg Preparation Reference | Preparation-level calculation reference | 10 mg reference amount | 1000 units / 10.00 mL |
| 20 mg Preparation Reference | Preparation-level calculation reference | 20 mg reference amount | 2000 units / 20.00 mL |
Common Research Windows
| Reference Window | Common Length | Research Notes |
|---|---|---|
| Cell-Culture / Neuropeptide Marker Window | 24–72 hours | May be used for peptide-response documentation, receptor-pathway screening, stress-response marker tracking, monoamine-marker observation, or cellular-response research depending on the model. |
| Acute Sleep / CNS Observation Window | Single session to several days | Used for short-term sleep-marker, EEG-related, neuroendocrine-marker, stress-response, or CNS pathway observations depending on the research design. |
| Short Research Window | 1–2 weeks | May be used for early controlled observation involving sleep-quality markers, stress-response markers, neuroendocrine markers, or CNS-related endpoints. |
| Standard Protocol-Style Window | 2–4 weeks | Commonly used in public protocol-style references for structured observation and comparison across baseline and follow-up periods. |
| Extended Observation Window | 4–8 weeks | Used when longer documentation is needed for sleep-marker trends, stress-response marker comparison, endocrine-marker tracking, or follow-up observation. |
| Follow-Up / Washout | 1–4 weeks | Used to document post-study observations, marker return, delayed response patterns, or follow-up data depending on the research model. |
Research Note: These tables are provided for educational, research-planning, concentration, frequency-reference, and volume-reference purposes only. DSIP, also referenced as delta sleep-inducing peptide, is commonly discussed in sleep-marker, EEG delta-wave, neuropeptide, neuroendocrine, stress-response, respiration, monoamine-marker, serotonin-marker, metabolic-disturbance, and CNS research contexts. The selector above updates calculations for 2 mg, 5 mg, and 10 mg vial references reconstituted with 2.0 mL bacteriostatic water, and a 20 mg vial reference reconstituted with 3.0 mL bacteriostatic water. Published study references, clinical-study contexts, public protocol-style references, or wellness protocols are not universal research-chemical dosing standards and should not be treated as dosing instructions for research-chemical vial formats. This information is not medical advice, dosing instruction, injectable-use guidance, or a recommendation for human or animal use.
Research Notes
Research Findings & Safety Notes
Research Findings
DSIP is commonly discussed in research involving sleep architecture, delta-wave sleep, sleep latency, sleep efficiency, neuroendocrine markers, and stress-response signaling.
Study Limitations
DSIP research includes small and older human studies with mixed findings. Current evidence does not establish a standardized clinical dosing protocol or approved therapeutic use.
Safety Considerations
Laboratory handling should include appropriate PPE, sterile technique, proper labeling, batch documentation, and qualified research procedures.
Use Restriction
Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Related Supplies
Research Supplies
For research supplies, visit our affiliate partner and use code PLHQ10 to save 10% on your order.
Bacteriostatic Water
Commonly referenced in laboratory preparation workflows.
Research Syringes
Supply category for controlled laboratory research preparation.
Prep Supplies
Supporting supplies for clean handling, preparation, and documentation.
Lab Handling
Handling & Storage
Storage
Store materials according to product-specific requirements. Protect from excessive heat, moisture, and direct light.
After Reconstitution
Keep refrigerated after reconstitution unless otherwise specified by the product documentation.
Handling
Use appropriate laboratory PPE, clean handling practices, and qualified research procedures.
Documentation
Maintain batch details, COA records, preparation notes, and internal research documentation.